| 摘要 |
The present invention relates to formulation based on: (i) micronized clinoptilolite (Me-MC) of enhanced mesoporosity of general formula: (Men+)x/n [(A1O2)?(SiO2)y] mH2O (Me-MC) where Me= H, Li, Na, K, Mg, Ca, Zn, Ag, Cu, Mn, or Fe; whereas ratio of silicon to aluminum, y:x is between 3:1 and 6:1; number of crystalline water m is from 0 to >10; which is characterized by particles size from 100 nm to 2 µm, BET total surface area larger than 30 m2/g, total mesoporous surface area larger than 15 m2/g, and with portion of mesoporous surface area within BET total surface area of at least 50%; and (ii) one or more excipients which yield in desired pharmaceutical form: tablets, capsules, ointments, creams, gels, lotions, powders, liquid powders, compact powders, masks, suspensions, syrups, and therapeutic patches. The formulation of the present invention provides more effective elimination of toxins from human or animal organism such as: (i) micotoxins; (ii) polycyclic aromatic hydrocarbons; (iii) nitrosamines; (iv) heavy metals; (v) toxic aliphatic or aromatic amines; (vi) acrylamide; (vii) dioxins; and for removal of (viii) bacteria; and (ix) viruses; which enter through gastrointestinal tract, by breathing, or through skin and/or mucous membranes. In this manner, numerous harmful effects of these toxins, bacteria, and viruses on human or animal organisms can be more effectively prevented.
|
